Evidence-Based Tobacco Cessation Strategies in Patients With Cancer
2. juli 2018 opdateret af: Wake Forest University Health Sciences
Implementing Evidence-Based Tobacco Cessation Strategies in Oncology Clinics
This pilot clinical trial studies evidence-based tobacco cessation strategies in patients with cancer.
Stop-smoking plans suggested by doctors may help patients with cancer quit smoking.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
PRIMARY OBJECTIVES:
I. To assess oncology providers' self-reported need for training on evidence-based tobacco cessation strategies and assess their level of interest in future training on evidence-based tobacco cessation strategies.
II. To test the feasibility of the implementation of evidence-based tobacco cessation strategies in community oncology clinics.
III. To test the feasibility of surveying community oncology patients after a clinic visit to assess provider behavior regarding screening and brief intervention for tobacco use.
OUTLINE:
Patients complete a survey over approximately 10-15 minutes related to their provider's cessation advice and assistance with quitting.
After completion of study, patients are followed up at 1 month.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
377
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
North Carolina
-
Winston-Salem, North Carolina, Forenede Stater, 27157
- Comprehensive Cancer Center of Wake Forest University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- All patients with cancer who saw a provider will be eligible
Exclusion Criteria:
- Having a nurse or lab visit only
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Health Services Research (smoking cessation intervention)
Participants complete a survey over approximately 10-15 minutes related to their provider's cessation advice and assistance with quitting.
|
Hjælpestudier
Hjælpestudier
Receive evidence-based tobacco cessation strategies
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Percentage of providers from the Piedmont Oncology Association (POA) reporting a need for training on evidence-based tobacco cessation strategies
Tidsramme: Up to 1 month
|
Will be estimated and 95% confidence intervals (CI) constructed.
|
Up to 1 month
|
|
Percentage reporting feeling very confident in their ability to counsel smokers
Tidsramme: Up to 1 month
|
Will be estimated and 95% CI constructed.
|
Up to 1 month
|
|
Percentage reporting they would be willing to participate in training on evidence-based tobacco cessation strategies
Tidsramme: Up to 1 month
|
Will be estimated and 95% CI constructed.
|
Up to 1 month
|
|
Proportion of oncology patients willing to complete a survey in an oncology clinic
Tidsramme: Up to 1 month
|
Will be estimated and 95% CI constructed.
|
Up to 1 month
|
|
Proportion of patients who report that their provider asked about tobacco use during their visit
Tidsramme: Up to 1 month
|
These prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes.
These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics.
|
Up to 1 month
|
|
Proportion of current smokers who report that their provider advised them to quit during their visit and provided tobacco-cessation strategies
Tidsramme: Up to 1 month
|
These prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes.
These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics.
|
Up to 1 month
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Erin Sutfin, Wake Forest University Health Sciences
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. februar 2013
Primær færdiggørelse (Faktiske)
1. november 2014
Studieafslutning (Faktiske)
1. november 2014
Datoer for studieregistrering
Først indsendt
5. august 2014
Først indsendt, der opfyldte QC-kriterier
5. august 2014
Først opslået (Skøn)
7. august 2014
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
3. juli 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
2. juli 2018
Sidst verificeret
1. juli 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRB00021885
- P30CA012197 (U.S. NIH-bevilling/kontrakt)
- NCI-2014-01572 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- CCCWFU #99413 (Anden identifikator: Comprehensive Cancer Center of Wake Forest University)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .